Near-infrared fluorescence imaging of liver metastases from gastroenteropancreatic neuroendocrine neoplasms using indocyanine green

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24525

Enrollment

Registered

2020-07-27

Start date

2019-11-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroendocrine liver metastases

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • Age of 18 years and older; • All patients undergoing surgery for NELM; • Patients eligible for ICG infusion 24h prior to surgery according to the hospital protocol.

Exclusion criteria

Exclusion criteria: • Allergy to ICG, iodide or sodium iodide; • Hyperthyroidism or benign thyroid tumour; • Thyroid examination using radioactive iodide <1 week; • Breast-feeding; • No informed consent.

Design outcomes

Primary

Measure	Time frame
To determine the radical resection rate.	—

Secondary

Measure	Time frame
- Percentage of additional malignant lesions identified with NIRF; - Additional (micro-)metastases found by FA; - Perioperative parameters (blood loss, operation time, hospital stay); - Long-term oncological outcomes (overall survival, disease free survival).	—

Contacts

Public ContactEnes Kacmaz

Department of Surgery, Amsterdam UMC

e.kacmaz@amsterdamumc.nl020-5662153

Outcome results